TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32214296

Group type: EXPERIMENTAL
Intervention: Hyalase + 10 mL saline solution injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: 10 mL saline solution only
Number of subjects: 60
Study: 34448748

Group type: EXPERIMENTAL
Intervention: Respiratory syncytial virus (RSV)
Number of subjects: 882

Group type: EXPERIMENTAL
Intervention: Tuberculosis (TB)
Number of subjects: 882
Study: 32997666

Group type: EXPERIMENTAL
Intervention: Micronutrient and EED Assessment Tool (MEEDAT)
Number of subjects: 300
Study: 33267591

Group type: EXPERIMENTAL
Intervention: Almagate (1.5 g)
Number of subjects: 0
Study: 35301643

Group type: EXPERIMENTAL
Intervention: Heart Health Now intervention (education tools, onsite practice facilitation for one year, practice-specific cardiovascular population management dashboard)
Number of subjects: 28
Study: 34306599

Group type: EXPERIMENTAL
Intervention: Tai Chi softball (TCSB) training program
Number of subjects: 100

Group type: COMPARATOR
Intervention: Physical exercise group
Number of subjects: 100
Study: 32624208

Group type: EXPERIMENTAL
Intervention: Augmented locking plate fixation (Group LP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intramedullary nailing (Group IN)
Number of subjects: 60
Study: 35932526

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of bilateral thalamic centromedian nucleus for 3 months
Number of subjects: 19
Study: 32364518

Group type: EXPERIMENTAL
Intervention: PCOS group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 35380664

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 0
Study: 33496985

Group type: EXPERIMENTAL
Intervention: Resistance training + saffron (RTS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Saffron (S)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (CO)
Number of subjects: 100
Study: 35773711

Group type: EXPERIMENTAL
Intervention: Phasic muscle therapy protocol using the StimaWELL 120MTRS system
Number of subjects: 30

Group type: COMPARATOR
Intervention: Combined muscle therapy protocol (phasic + tonic) using the StimaWELL 120MTRS system
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both interventions (phasic and combined)
Number of subjects: 30
Study: 33792839

Group type: COMPARATOR
Intervention: Standard peritoneal lavage (SPL)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Extensive intraoperative peritoneal lavage (EIPL)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Laparoscopic approach
Number of subjects: 94
Study: 32272256

Group type: EXPERIMENTAL
Intervention: No-touch technique for saphenous vein grafts (SVGs)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Conventional open skeletonized technique for saphenous vein grafts (SVGs)
Number of subjects: 900
Study: 36244527

Group type: EXPERIMENTAL
Intervention: Gabapentin (1800 mg/day)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (0 mg/day)
Number of subjects: 13
Study: 34531218

Group type: EXPERIMENTAL
Intervention: Autologous fat transfer (AFT)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Tissue-expander/prosthesis
Number of subjects: 196
Study: 33200808

Group type: EXPERIMENTAL
Intervention: Polysaccharide hemostatic powder (PHP)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: PHP (in subgroup analysis excluding antithrombotic agents)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control (in subgroup analysis excluding antithrombotic agents)
Number of subjects: 143
Study: 32078948

Group type: EXPERIMENTAL
Intervention: Peginterferon beta‐1a 125 mcg every 2 weeks
Number of subjects: 1243
Study: 34501636

Group type: EXPERIMENTAL
Intervention: Door-to-door hang-up visits
Number of subjects: 4276

Group type: COMPARATOR
Intervention: Conventional fixed distribution from distribution centers with mass distribution campaign
Number of subjects: 4276
Study: 32141858

Group type: EXPERIMENTAL
Intervention: Oxidative stress measured by malondialdehyde (MDA) content
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Antioxidant activity measured by catalase (CAT) content
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Heart Rate Variability (HRV) analysis before physical activity
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: HRV spectral analysis before physical activity
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: HRV time analysis after physical activity
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: HRV spectral analysis after physical activity
Number of subjects: 81
Study: 35426796

Group type: EXPERIMENTAL
Intervention: Model group (n=856)
Number of subjects: 1141

Group type: EXPERIMENTAL
Intervention: Validation group (n=258)
Number of subjects: 1141

Group type: COMPARATOR
Intervention: High-risk group (identified by the risk score model)
Number of subjects: 1141

Group type: COMPARATOR
Intervention: Risk factors identified
Number of subjects: 1141

Group type: COMPARATOR
Intervention: Risk score model
Number of subjects: 1141
Study: 32368344

Group type: EXPERIMENTAL
Intervention: Total Resistance exercises (TRX)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Aquatic training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study: 35731136

Group type: EXPERIMENTAL
Intervention: Cholesterol efflux capacity (CEC) of serum high-density lipoprotein (HDL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum HDL cholesterol (HDL-C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum ApoA1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decline in CEC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CEC and ApoA1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Faster decliners in CEC
Number of subjects: 0
Study: 33691647

Group type: EXPERIMENTAL
Intervention: Therap-i module integrated into treatment as usual (TAU) for depression
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (TAU without Therap-i module)
Number of subjects: 100
Study: 32187977

Group type: EXPERIMENTAL
Intervention: Child Restraint System (CRS) usage
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Injury related to unrestrained children
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Injury Severity Score (ISS)
Number of subjects: 19
Study: 35584882

Group type: EXPERIMENTAL
Intervention: Brief intervention group
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Financial incentive group
Number of subjects: 440

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 440
Study: 33183935

Group type: EXPERIMENTAL
Intervention: Propofol-based total intravenous anesthesia
Number of subjects: 500

Group type: COMPARATOR
Intervention: Volatile anesthesia
Number of subjects: 500
Study: 33104761

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) and psychopharmacology within a collaborative care model
Number of subjects: 187

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: HDRS6
Number of subjects: 187
Study: 35524492

Group type: EXPERIMENTAL
Intervention: Chitosan-based hydrocolloid dressing
Number of subjects: 80

Group type: COMPARATOR
Intervention: Inert saline gauze
Number of subjects: 80
Study: 33855672

Group type: EXPERIMENTAL
Intervention: Escalation Workshop
Number of subjects: 335
Study: 35954675

Group type: EXPERIMENTAL
Intervention: Home-based exercise program (2 sessions of 60 minutes per week for 9 months)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (habitual leisure-time activities)
Number of subjects: 54
Study: 33047258

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Brief Advice (BA)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Both interventions (MI and BA)
Number of subjects: 110
Study: 32448335

Group type: EXPERIMENTAL
Intervention: Apatinib mesylate (500 mg, once daily) combined with vinorelbine (40 mg, thrice a week)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Vinorelbine alone (40 mg, thrice a week)
Number of subjects: 238
Study: 33515781

Group type: EXPERIMENTAL
Intervention: TAKE IT intervention (multifaceted medication adherence monitoring strategy)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 450
Study: 32179587

Group type: EXPERIMENTAL
Intervention: Nurse-coordinated referral with a comprehensive set of three lifestyle interventions (physical activity, weight reduction, smoking cessation)
Number of subjects: 824

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 824
Study: 33910103

Group type: EXPERIMENTAL
Intervention: Customized 3D-printed guiding template (Group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Endoscopic type I tympanoplasty without template (Group 1)
Number of subjects: 60
Study: 32142572

Group type: EXPERIMENTAL
Intervention: Collagen membrane (membrane group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No collagen membrane (no-membrane group)
Number of subjects: 20
Study: 36066557

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 530

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study: 34022839

Group type: EXPERIMENTAL
Intervention: Food Education and Sustainability Training (FEAST) program, delivered as a 1.5-h lesson/week for 10 weeks.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Wait-list control group (no intervention).
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Food literacy constructs including nutrition knowledge, food preparation and cooking skills, self-efficacy and behaviours, food waste knowledge and behaviours, and food production knowledge.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Process evaluation measures including program reach, adoption, implementation, maintenance, satisfaction, and perceived benefits by teachers and students.
Number of subjects: 20
Study: 35384335

Group type: EXPERIMENTAL
Intervention: Modified Giemsa Stain (MGS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Leishman method
Number of subjects: 30

Group type: COMPARATOR
Intervention: May Grunwald Giemsa method (MGG)
Number of subjects: 30
Study: 32723486

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT)
Number of subjects: 61
Study: 35925872

Group type: EXPERIMENTAL
Intervention: Individualized nutritional interventions with normoproteic diets (1.0 g/kg) after 60 days of KTx
Number of subjects: 174

Group type: COMPARATOR
Intervention: Standard nutritional guidance for the post‐KTx period
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Individualized nutritional interventions
Number of subjects: 174

Group type: COMPARATOR
Intervention: Standard nutritional guidance
Number of subjects: 174
Study: 33285746

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no music intervention)
Number of subjects: 0
Study: 35595091

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10mg daily in addition to standard care
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Placebo in addition to standard care
Number of subjects: 5000
Study: 34266721

Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy (ESWT)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Dextrose Prolotherapy
Number of subjects: 29
Study: 32698962

Group type: EXPERIMENTAL
Intervention: 4D‐CT
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3D‐CT
Number of subjects: 0
Study: 616845601

Group type: EXPERIMENTAL
Intervention: Normoxic bed rest (NBR)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hypoxic ambulatory confinement (HAMB)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hypoxic bed rest (HBR)
Number of subjects: 11
Study: 35972927

Group type: EXPERIMENTAL
Intervention: Mazao Tickoff (active ingredient: M. anisopliae ICIPE 7)
Number of subjects: 1077

Group type: EXPERIMENTAL
Intervention: Triatix® (active ingredient: amitraz)
Number of subjects: 1077

Group type: COMPARATOR
Intervention: Placebo (excipients of the Mazao Tickoff)
Number of subjects: 1077

Group type: EXPERIMENTAL
Intervention: Mazao Tickoff
Number of subjects: 1077
Study: 33772710

Group type: EXPERIMENTAL
Intervention: Intervention (5-week program)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control (no-treatment)
Number of subjects: 91
Study: 32668114

Group type: EXPERIMENTAL
Intervention: Accelerated strategy of renal-replacement therapy (initiated within 12 hours)
Number of subjects: 2927

Group type: COMPARATOR
Intervention: Standard strategy of renal-replacement therapy (initiated after 72 hours or conventional indications)
Number of subjects: 2927

Group type: EXPERIMENTAL
Intervention: Accelerated strategy of renal-replacement therapy
Number of subjects: 2927

Group type: COMPARATOR
Intervention: Standard strategy of renal-replacement therapy
Number of subjects: 2927
Study: 35087261

Group type: EXPERIMENTAL
Intervention: Individually tailored intervention focused on reducing food waste during dining
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individually tailored intervention
Number of subjects: 0
Study: 37436461

Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC, 45–60 s postpartum)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Early cord clamping (ECC, < 10 s postpartum)
Number of subjects: 96
Study: 32604130

Group type: EXPERIMENTAL
Intervention: Cloud-based early warning score (mNEWS) intervention
Number of subjects: 1741

Group type: COMPARATOR
Intervention: Control group (no cloud-based early warning score)
Number of subjects: 1741
Study: 35377866

Group type: EXPERIMENTAL
Intervention: Dabrafenib, trametinib, and hydroxychloroquine (experimental arm)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Dabrafenib and trametinib (contemporary control arm)
Number of subjects: 14
Study: 33980201

Group type: EXPERIMENTAL
Intervention: Personalized eHealth intervention including psycho-education, stress-management training (Heart Rate Variability-biofeedback), and a personalized stop-smoking plan.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personalized eHealth intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (webpage with information on pregnancy, stress, and smoking cessation)
Number of subjects: 0
Study: 32531798

Group type: EXPERIMENTAL
Intervention: CZP 200 mg every two weeks (Q2W) (400 mg at Weeks 0, 2, 4)
Number of subjects: 995

Group type: EXPERIMENTAL
Intervention: CZP 400 mg every two weeks (Q2W)
Number of subjects: 995

Group type: EXPERIMENTAL
Intervention: All patients (combined CZP groups)
Number of subjects: 995

Group type: EXPERIMENTAL
Intervention: CZP 200 mg Q2W
Number of subjects: 995

Group type: EXPERIMENTAL
Intervention: CZP 400 mg Q2W
Number of subjects: 995

Group type: EXPERIMENTAL
Intervention: CZP 200 mg Q2W and CZP 400 mg Q2W
Number of subjects: 995

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 995
Study: 36464237

Group type: EXPERIMENTAL
Intervention: 2 Hz electroacupuncture treatment
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: 20/100 Hz electroacupuncture treatment
Number of subjects: 174

Group type: COMPARATOR
Intervention: Sham electroacupuncture treatment
Number of subjects: 174
Study: 32388512

Group type: EXPERIMENTAL
Intervention: Two-step anesthesia
Number of subjects: 90

Group type: COMPARATOR
Intervention: Peribulbar anesthesia
Number of subjects: 90

Group type: COMPARATOR
Intervention: Retrobulbar anesthesia
Number of subjects: 90
Study: 32734929

Group type: EXPERIMENTAL
Intervention: Self-myofascial release intervention with a foam roller
Number of subjects: 70
Study: 34499116

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 554
Study: 34134645

Group type: EXPERIMENTAL
Intervention: Chronic anticoagulation therapy
Number of subjects: 1032

Group type: COMPARATOR
Intervention: No anticoagulation therapy (Control)
Number of subjects: 1032
Study: 32009464

Group type: EXPERIMENTAL
Intervention: Email/mail outreach in Phase 1
Number of subjects: 185150

Group type: EXPERIMENTAL
Intervention: Brochure outreach in Phase 2
Number of subjects: 185150

Group type: COMPARATOR
Intervention: Overall recruitment in Phase 1
Number of subjects: 185150

Group type: COMPARATOR
Intervention: Overall recruitment in Phase 2
Number of subjects: 185150
Study: 36140688

Group type: EXPERIMENTAL
Intervention: Genotype F18
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Genotype F49
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Genotypes P13 and P5
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Overall genotypes
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Combined analysis
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cluster analysis
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: PC analysis
Number of subjects: 21
Study: 33354803

Group type: EXPERIMENTAL
Intervention: Improvac® (two doses, 28 days apart)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo treatments
Number of subjects: 19
Study: 35016426

Group type: EXPERIMENTAL
Intervention: Psychological nursing intervention
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard nursing intervention
Number of subjects: 140
Study: 32026836

Group type: EXPERIMENTAL
Intervention: Water-based exercise training (WG)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Land-based exercise training (LG)
Number of subjects: 50
Study: 35058251

Group type: EXPERIMENTAL
Intervention: Total flavonoid intake (highest quintile)
Number of subjects: 55413

Group type: EXPERIMENTAL
Intervention: Flavonoid subclasses (highest intake)
Number of subjects: 55413

Group type: EXPERIMENTAL
Intervention: Total flavonoid intake (current smokers)
Number of subjects: 55413

Group type: EXPERIMENTAL
Intervention: Total flavonoid intake (former smokers)
Number of subjects: 55413

Group type: COMPARATOR
Intervention: Flavonoid intake
Number of subjects: 55413
Study: 33998067

Group type: EXPERIMENTAL
Intervention: HPβ-CD Ang-(1–7)
Number of subjects: 60

Group type: COMPARATOR
Intervention: HPβ-CD
Number of subjects: 60
Study: 33434503

Group type: EXPERIMENTAL
Intervention: Triple-normal LNs (defined as cN0 on CT scanning, PET scanning, and CLNS evaluation)
Number of subjects: 57
Study: 34318743

Group type: COMPARATOR
Intervention: Peripherally inserted central catheters (n=212)
Number of subjects: 1061

Group type: COMPARATOR
Intervention: PORTs (n=253)
Number of subjects: 1061

Group type: COMPARATOR
Intervention: PORTs (n=147)
Number of subjects: 1061
Study: 32744184

Group type: EXPERIMENTAL
Intervention: Proactive maternal observation of fetal movements
Number of subjects: 623

Group type: COMPARATOR
Intervention: Routine-care (Control)
Number of subjects: 623
Study: 36368992

Group type: EXPERIMENTAL
Intervention: Android-based self-care application
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 60
Study: 33756524

Group type: EXPERIMENTAL
Intervention: 10% MVC static exercise
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 30% MVC static exercise
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 10% MVC dynamic exercise
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 30% MVC dynamic exercise
Number of subjects: 45
Study: 34400199

Group type: EXPERIMENTAL
Intervention: REP + LPRF
Number of subjects: 23

Group type: COMPARATOR
Intervention: REP - LPRF
Number of subjects: 23
Study: 32456572

Group type: EXPERIMENTAL
Intervention: Hemp Oil Extract (60 mg/d, 15 mg hemp-derived CBD)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 65
Study: 33620619

Group type: EXPERIMENTAL
Intervention: Active esophageal cooling using the Attune Medical Esophageal Heat Transfer Device (EnsoETM)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard temperature monitoring (control group)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Adjunctive posterior wall isolation
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 44
Study: 33866000

Group type: EXPERIMENTAL
Intervention: BNT162b2 mRNA vaccine
Number of subjects: 803
Study: 37306270

Group type: EXPERIMENTAL
Intervention: Positive pressure extubation (PPE) with pressure support of 15 cm H2O and positive end expiratory pressure of 10 cm H2O for 5 minutes
Number of subjects: 70

Group type: COMPARATOR
Intervention: Traditional extubation (TE)
Number of subjects: 70
Study: 34836429

Group type: EXPERIMENTAL
Intervention: HAPIFED (integrates cognitive behavioural therapy with body weight loss therapy)
Number of subjects: 98

Group type: COMPARATOR
Intervention: CBT‐E (cognitive behavioural therapy with extended sessions alone)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: HAPIFED
Number of subjects: 98
Study: 32558044

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 33356033

Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors in addition to baseline treatment (Group A)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Baseline treatment or other medications as needed (Group B)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Healthy controls (Group C)
Number of subjects: 97
Study: 34746955

Group type: COMPARATOR
Intervention: ExComb (HIIT and MICT combined)
Number of subjects: 1567

Group type: COMPARATOR
Intervention: HIIT (high-intensity interval training)
Number of subjects: 1567

Group type: COMPARATOR
Intervention: MICT (moderate-intensity continuous training)
Number of subjects: 1567

Group type: EXPERIMENTAL
Intervention: Control (instructed to follow physical activity recommendations)
Number of subjects: 1567

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1567
Study: 33325066

Group type: EXPERIMENTAL
Intervention: Family nursing therapeutic conversations
Number of subjects: 468

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 468
Study: 36429537

Group type: EXPERIMENTAL
Intervention: Technological rehabilitation (TG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional rehabilitation (CG)
Number of subjects: 30
Study: 32807060

Group type: EXPERIMENTAL
Intervention: High uric acid tertile
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: High uric acid group
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Medium uric acid group
Number of subjects: 671

Group type: COMPARATOR
Intervention: Uric acid tertiles
Number of subjects: 671
Study: 35429485

Group type: EXPERIMENTAL
Intervention: Once-daily risdiplam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0